Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

RETRACTED: Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 1, pp. 105949-105949
Open Access | Times Cited: 4850

Showing 26-50 of 4850 citing articles:

COVID‐19 and Older Adults: What We Know
Zainab Shahid, Ricci Kalayanamitra, Brendan McClafferty, et al.
Journal of the American Geriatrics Society (2020) Vol. 68, Iss. 5, pp. 926-929
Open Access | Times Cited: 878
Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards
Bernard La Scola, Marion Le Bideau, Julien Andréani, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2020) Vol. 39, Iss. 6, pp. 1059-1061
Open Access | Times Cited: 862
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
Jean‐Michel Molina, Constance Delaugerre, J. Le Goff, et al.
Médecine et Maladies Infectieuses (2020) Vol. 50, Iss. 4, pp. 384-384
Open Access | Times Cited: 780
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret, Jean‐Christophe Lagier, Philippe Parola, et al.
Travel Medicine and Infectious Disease (2020) Vol. 34, pp. 101663-101663
Open Access | Times Cited: 763
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Bingwen Liu, Min Li, Zhiguang Zhou, et al.
Journal of Autoimmunity (2020) Vol. 111, pp. 102452-102452
Open Access | Times Cited: 759
Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts
Jin Wang, Mengmeng Jiang, Xin Chen, et al.
Journal of Leukocyte Biology (2020) Vol. 108, Iss. 1, pp. 17-41
Open Access | Times Cited: 720
A Review of SARS-CoV-2 and the Ongoing Clinical Trials
Yung-Fang Tu, Chian‐Shiu Chien, Aliaksandr A. Yarmishyn, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 7, pp. 2657-2657
Open Access | Times Cited: 708
COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
Anant Parasher
Postgraduate Medical Journal (2020) Vol. 97, Iss. 1147, pp. 312-320
Open Access | Times Cited: 705
Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
Nicholas J. Mercuro, Christina Yen, David Shim, et al.
JAMA Cardiology (2020) Vol. 5, Iss. 9, pp. 1036-1036
Open Access | Times Cited: 701
COVID-19 and the Heart
Akbarshakh Akhmerov, Eduardo Marbán
Circulation Research (2020) Vol. 126, Iss. 10, pp. 1443-1455
Closed Access | Times Cited: 670
COVID-19: Immunology and treatment options
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions
Yvan Jamilloux, Thomas Henry, Alexandre Bélot, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102567-102567
Open Access | Times Cited: 651
SARS-CoV-2 detection, viral load and infectivity over the course of an infection
Kieran Walsh, Karen Jordan, Barbara Clyne, et al.
Journal of Infection (2020) Vol. 81, Iss. 3, pp. 357-371
Open Access | Times Cited: 649
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies
Atul Sharma, Swapnil Tiwari, Manas Kanti Deb, et al.
International Journal of Antimicrobial Agents (2020) Vol. 56, Iss. 2, pp. 106054-106054
Open Access | Times Cited: 644
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
COVID-19: A Review on the Novel Coronavirus Disease Evolution, Transmission, Detection, Control and Prevention
Anshika Sharma, Isra Ahmad Farouk, Sunil K. Lal
Viruses (2021) Vol. 13, Iss. 2, pp. 202-202
Open Access | Times Cited: 598
Outcomes of Hydroxychloroquine Usage in United States Veterans Hospitalized with COVID-19
Joseph Magagnoli, Siddharth Narendran, Felipe Pereira, et al.
Med (2020) Vol. 1, Iss. 1, pp. 114-127.e3
Open Access | Times Cited: 585
Candidate drugs against SARS-CoV-2 and COVID-19
Dwight L. McKee, Ariane Sternberg, Ulrike Stange, et al.
Pharmacological Research (2020) Vol. 157, pp. 104859-104859
Open Access | Times Cited: 577
Treatment with hydroxychloroquine, azithromycin, and combination in patients hospitalized with COVID-19
Samia Arshad, Paul E. Kilgore, Zohra Chaudhry, et al.
International Journal of Infectious Diseases (2020) Vol. 97, pp. 396-403
Open Access | Times Cited: 556
Description and Proposed Management of the Acute COVID-19 Cardiovascular Syndrome
Nicholas Hendren, Mark H. Drazner, Biykem Bozkurt, et al.
Circulation (2020) Vol. 141, Iss. 23, pp. 1903-1914
Open Access | Times Cited: 550
Novel 2019 coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment
Subramanian Boopathi, Adolfo B. Poma, P. Kolandaivel
Journal of Biomolecular Structure and Dynamics (2020), pp. 1-10
Open Access | Times Cited: 540
A systematic review of SARS-CoV-2 vaccine candidates
Yetian Dong, Tong Dai, Yujun Wei, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 538
Cytokine storm induced by SARS-CoV-2
Peipei Song, Wei Li, Jianqin Xie, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 280-287
Open Access | Times Cited: 536
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 521
Treatment options for COVID-19: The reality and challenges
Shio-Shin Jean, Ping‐Ing Lee, Po‐Ren Hsueh
Journal of Microbiology Immunology and Infection (2020) Vol. 53, Iss. 3, pp. 436-443
Open Access | Times Cited: 516

Scroll to top